Clinical Trials Browser

Phase 4 × S 1 (combination) × Clear all

NCT06779318 2025-04-03

Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis

Phase 4 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06169410 2024-01-23

Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer

Phase 4 Unknown

Gastrointestinal

Advanced Gastric Cancer

NCT04217096 2020-01-03

Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients

Phase 4 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

NCT02945267 2016-10-26

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Phase 4 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT01997957 2013-11-28

SOON

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT01849380 2013-05-08

Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer

Phase 4 Unknown

Breast Neoplasms